Skip to Content
Merck

Effects of boric acid and borax on titanium dioxide genotoxicity.

Journal of applied toxicology : JAT (2007-11-21)
Hasan Turkez
ABSTRACT

Titanium dioxide (TiO(2)) is a potential carcinogenic/mutagenic agent although it is used in many areas including medical industries and cosmetics. Boron (as boric acid and borax) has also well-described biological effects and therapeutic benefits. In a previous study, sister-chromatid exchanges (SCEs) and micronuclei (MN) rates were assessed in control and TiO(2)-treated (1, 2, 3, 5, 7.5 and 10 microm) human whole blood cultures. The results showed that the rates of SCE (at 2, 3, 5, 7.5 and 10 microm) and MN (at 5, 7.5 and 10 microm) formation in peripheral lymphocytes were increased significantly by TiO(2) compared with the controls. The present study also investigated the genetic effects of boric acid and borax (2.5, 5 and 10 microm) on cultures with and without TiO(2) addition. No significant increase in SCE and MN frequencies were observed at all concentrations of boron compounds. However, TiO(2)-induced SCE and MN could be reduced significantly by the presence of boric acid and borax. In conclusion, this study indicated for the first time that boric acid and borax led to an increased resistance of DNA to damage induced by TiO(2).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sodium tetraborate decahydrate, BioXtra, ≥99.5%
Sigma-Aldrich
Sodium tetraborate decahydrate, puriss., meets analytical specification of Ph. Eur., BP, NF, 99.0-103.0%
Sigma-Aldrich
Sodium tetraborate decahydrate, puriss. p.a., ACS reagent, reag. ISO, buffer substance, ≥99.5%
Sigma-Aldrich
Sodium tetraborate decahydrate, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Sodium tetraborate decahydrate, ACS reagent, ≥99.5%